Skip to main content

Chase Knickerbocker

Analyst

Craig-Hallum Capital Group

Analyst

Craig-Hallum

Equibles does not estimate personal net worth.

About Chase Knickerbocker

Chase Knickerbocker is recorded as Analyst at Craig-Hallum Capital Group and Analyst at Craig-Hallum. Chase Knickerbocker has spoken on 30 earnings calls and 2 other investor events across 19 companies, most recently for Eton Pharmaceuticals, Inc. on August 13, 2026. Those appearances were for CVRx, Inc. (CVRX), Eton Pharmaceuticals, Inc. (ETON), Xtant Medical Holdings, Inc. (XTNT), Phathom Pharmaceuticals, Inc. (PHAT), Harrow, Inc. (HROW) and 14 other companies. The companies whose calls Chase Knickerbocker spoke on are classified in the Healthcare sector.

Chase Knickerbocker on recent calls

“Thanks for taking the questions, and congrats on a really great quarter here. um maybe just first from maybe just first from me on on hemangiol can you give us a sense for what the net realized price is in the quarter now that we have a couple months under our belt how does that compare um to the to kind of eight to…”
Analyst — Craig-Hallum, Eton Pharmaceuticals Q2 2026 Earnings Call ·
“Mark, maybe just first to start on the national top three PBM win. And can you just maybe talk about exactly what that coverage constitutes? Is it kind of tier one preferred like that other top three win that you already have?”
Analyst — Craig-Hallum, Second Quarter 2026 Earnings Conference Call and Webcast ·
“Now, regarding the Dillon Salesforce, and just your overall Salesforce, Exactly when in the quarter did they start or restart promoting products following training?”
Analyst — Craig-Hallum, Xtant Medical Holdings, Inc. Q2 FY2026 Earnings Call ·
“I just wanted to dig in a little bit more on kind of the implied kind of second half in your guidance. And so if we kind of look at that, you know, it assumes a pretty meaningful kind of slowdown still.”
Analyst — Craig-Hallum, Earnings conference call (announced in 8-K) ·
“Kevin, maybe it would be helpful for us if you could kind of present us with some like a cohort of sorts as far as kind of the reps where you're still seeing that, you know, kind of double digit growth that you mentioned, kind of, you know, what portion of your rep base are you still seeing that in?”
Analyst — Craig-Hallum Capital Group, CVRx Q2 2026 Earnings Call ·

Affiliation history

  • Craig-Hallum Capital Group

    Analyst

    Source not stated

    Current
  • Craig-Hallum

    Analyst

    Source not stated

    Current

Company network

Recent activity

Show 20 earlier activities